Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Candel Therapeutics, Inc. is a BLA-ready clinical-stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic antitumor immune response to help patients fight cancer. CAN-2409 is the lead product candidate from the adenovirus platform. CAN-3110 is the lead product candidate from the herpes simplex virus (HSV) platform and is in an ongoing phase Ib clinical trial in recurrent high-grade glioma. Its enLIGHTEN Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. CAN-2409, Its advanced multimodal biological immunotherapy candidate, is an investigational, off-the-shelf, replication-defective adenovirus engineered to deliver the herpes simplex virus thymidine kinase (HSV-tk) gene to a patient’s specific tumor and induce an individualized, systemic immune response against the tumor.
Find out what a historical investment in Candel Therapeutics Inc would be worth today using our CADL stock calculator.
Buying CADL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Candel Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in CADL
What is the ticker symbol of Candel Therapeutics Inc?
The ticker symbol for Candel Therapeutics Inc is CADL.
How much is one share of CADL?
One share of CADL is valued at $5.13 as of 20 November 2026.
What is the market capitalisation of Candel Therapeutics Inc CADL?
As of 20 November 2026 Candel Therapeutics Inc has a market cap of $417.33M.
What is the 52-week high for Candel Therapeutics Inc stock?
The Candel Therapeutics Inc 52-week high stock price is $14.00.
What is the 52-week low for Candel Therapeutics Inc stock?
The Candel Therapeutics Inc 52-week low stock price is $4.35.
Can I buy CADL shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CADL shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CADL on Stake
Buy CADL from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of CADL from only US$10 with fractional shares